Prosecutors say the scheduled West Palm Beach trial follows years of alleged conduct involving nationwide cardiovascular screening, disputed insurance billing, electronic medical approvals, and student-athlete safety concerns
WASHINGTON, DC, August 26, 2026 — The Justice Department has listed April 5, 2027, as the trial date for cardiologist Jason Finkelstein, placing the closely watched federal sports-medicine prosecution before Judge Aileen Cannon in the Southern District of Florida.
The official Justice Department case update identifies the West Palm Beach courthouse, docket number 26-cr-80123, presiding judge, trial date, September status conference, and March calendar call, which now shape public expectations for the proceeding.
Finkelstein has pleaded not guilty and remains presumed innocent, so the published date reflects a scheduled opportunity for prosecutors to prove their accusations before a jury, not a judicial conclusion about disputed medical, billing, or financial conduct.
The indictment alleges that conduct beginning around January 2019 and continuing through approximately December 2025 connected campus cardiovascular testing with false diagnoses, questionable professional reviews, inaccurate claims, interstate transmissions, insurer payments, and personal compensation received through related businesses.
Prosecutors describe an operation that submitted more than $89 million in allegedly false claims and generated more than $13.1 million in payments, but those figures remain unproven allegations whose legal meaning will depend upon admissible, transaction-specific evidence.
The April Date Gives the Case a Definite Public Horizon
By publishing the April 5 trial date, the Justice Department has supplied student athletes, families, schools, insurers, witnesses, and lawyers with a practical horizon for following a prosecution whose evidence may span dozens of institutions and several technical disciplines.
That horizon does not guarantee trial will begin exactly as scheduled, because federal criminal calendars can change through later judicial orders addressing discovery, motions, expert disputes, witness availability, counsel conflicts, negotiated resolutions, or other developments affecting fairness and readiness.
Until Cannon issues a different order, however, April 5 remains the operative trial setting, while a September 16, 2026, status conference and March 30, 2027, calendar call provide earlier checkpoints for evaluating preparation and unresolved procedural questions.
The schedule transforms an expansive indictment into a backward-running preparation calendar, requiring both sides to organize medical images, insurance data, campus communications, electronic logs, corporate records, bank information, witness testimony, expert analysis, and proposed courtroom exhibits.
Four Counts Will Direct the Jury’s Work
The indictment charges one count of conspiracy to commit healthcare fraud and wire fraud, followed by three substantive healthcare-fraud counts tied to identified claim transactions submitted during the broader period federal prosecutors describe.
For the conspiracy count, the government must prove that Finkelstein knowingly and willfully joined the charged agreement with the required unlawful purpose, because professional association, corporate ownership, medical-director status, or compensation does not automatically establish criminal participation.
The substantive counts focus on alleged executions or attempted executions involving healthcare benefit programs, materially false representations, money or property, and knowing conduct, requiring jurors to examine particular claims instead of relying exclusively upon the government’s aggregated financial narrative.
Defense attorneys can challenge whether the evidence connects Finkelstein personally with each required element, while prosecutors may introduce broader patterns to explain intent, knowledge, relationships, and the context surrounding the three transactions selected for substantive charges.
The Alleged Conduct Reached Campuses Across the Country
According to prosecutors, a Boca Raton cardiovascular company sent sonographers to college campuses throughout the United States, where student athletes received electrocardiograms, echocardiograms, and vascular ultrasound studies promoted as protection against sudden cardiac arrest.
The indictment alleges that marketing appealed directly to fears of catastrophic on-field death, sometimes presenting participation as necessary for team eligibility while describing the testing as carrying no direct cost for athletes whose insurance information supported later claims.
Athletic trainers or other referral sources allegedly received or were offered checks, wire transfers, gift cards, and related inducements, an accusation that may require school records and witness testimony establishing who received value, why, and with whose knowledge.
The defense may distinguish legitimate event coordination, administrative compensation, independent school policies, and preventive health concerns from unlawful inducements, insisting that the government prove both the nature of each arrangement and Finkelstein’s knowing involvement.
Uniform Testing Allegedly Replaced Individual Assessment
Prosecutors allege that sonographers administered substantially the same six-test panel to almost every participating athlete, even though no physician first conducted the individualized examination or assessment insurers allegedly required before reimbursing diagnostic cardiovascular services.
Screening can serve a preventive purpose without constituting fraud, making the trial’s central medical question more precise: whether particular tests were knowingly represented as individualized diagnostic services despite lacking the symptoms, examination, documentation, or necessity required for payment.
Medical experts may explain when an electrocardiogram, echocardiogram, or vascular study becomes clinically indicated, how screening differs from diagnosis, which professional standards govern interpretation, and whether reasonable practitioners could disagree about necessity under the recorded circumstances.
Jurors will need to separate contested screening policy, imperfect medical judgment, negligence, and documentation weakness from intentional deception, because federal criminal statutes demand considerably more than proof that another clinician might have ordered fewer tests.
False Diagnoses Allegedly Opened the Reimbursement Door
The indictment alleges that student questionnaires received false diagnosis codes, including hypertension or elevated blood pressure, so billers could present broadly offered screening encounters as medically necessary services eligible for payment by public and commercial benefit programs.
At trial, prosecutors may compare questionnaire answers, vital signs, medical histories, diagnosis entries, claim forms, coding instructions, metadata, employee communications, and payer rules to argue that the recorded conditions were deliberately manufactured rather than reasonably inferred.
The defense can examine whether ambiguous responses supported clinical concern, whether coders acted without Finkelstein’s direction, whether automated systems populated fields, and whether an inaccurate diagnosis resulted from misunderstanding, negligence, or conduct attributable to another participant.
Materiality will also matter, because jurors may hear whether truthful information would have influenced an insurer’s authorization or payment decision, rather than assuming that every mistaken code automatically created a legally significant fraudulent representation.
Service Locations and Provider Roles May Receive Close Scrutiny
Claims allegedly represented that testing occurred at Finkelstein’s Texas office even though sonographers performed services on distant campuses, potentially affecting network status, credentialing, supervision, reimbursement, and the payer’s understanding of where professional work actually occurred.
The government also alleges that Finkelstein appeared as the ordering, referring, or reviewing physician for services even though he had not examined athletes beforehand and sometimes did not meaningfully review the resulting cardiovascular images afterward.
Those accusations place claim fields at the center of the case, requiring evidence about who entered each code, what software carried forward automatically, which records Finkelstein could access, and what representations each payer considered important.
Defense lawyers may argue that administrative staff or billing vendors controlled data entry, that remote interpretation remained permissible, or that location conventions and provider designations varied, while prosecutors will seek evidence showing repeated and knowing misstatements.
Electronic Approval Times Could Become Powerful but Contested Evidence
Prosecutors say Finkelstein routinely signed cardiovascular results as normal within only seconds of accessing them electronically, even though many studies contained numerous images that allegedly required careful professional attention before a reliable medical interpretation could be completed.
Digital timestamps may appear mechanically precise, yet software specialists must explain authentication, clock synchronization, earlier access, downloaded images, preliminary readers, shared workstations, automated events, platform migrations, and whether historical exports capture the complete clinical workflow.
The government can compare access intervals with image volume, report complexity, internal messages, claim submissions, and witness accounts to show a consistent approval pattern incompatible with the meaningful review insurers and athletes claim.
The defense may respond that review occurred before the recorded event, through another interface, or with appropriate preliminary assistance, while challenging whether an electronic signature timestamp proves what the physician had already seen, considered, or discussed.
One Athlete’s Death Brings Exceptional Human Consequences
The indictment describes approximately 63 images from an October 2024 examination of one student athlete, some carrying unconfirmed preliminary references to possible right-sided heart enlargement before Finkelstein allegedly signed the entire collection as normal.
Prosecutors allege that approval occurred approximately eleven seconds after access and that the athlete died from sudden cardiac arrest around twenty-four days later, creating a deeply consequential episode whose emotional force will require careful evidentiary and judicial management.
Associated Press reporting described the case within a nationwide healthcare-fraud crackdown, recounting allegations that unnecessary athlete tests were certified as normal without meaningful personal review while also prominently reporting Finkelstein’s not-guilty plea in court.
The athlete’s death does not independently prove fraud, conspiracy, causation, or intent, and defense attorneys may contest preliminary annotations, platform timing, clinical significance, later medical findings, professional responsibility, and any asserted relationship between the examination and collapse.
The Financial Numbers Describe Different Questions
Prosecutors allege that more than $89 million in claims produced over $13.1 million in payments to accounts associated with Finkelstein’s professional entities, while approximately $1.1 million allegedly reached him through checks and wires during the charged period.
Those amounts represent different concepts, because billed charges, allowed payments, personal compensation, actual loss, intended loss, restitution, forfeiture, legitimate service value, business expenses, and criminal proceeds can require separate calculations and legal findings.
The indictment seeks an approximately $13.1 million forfeiture money judgment following qualifying convictions, but that demand is neither a present debt nor proof that every reimbursement can be traced to conduct satisfying the charged offenses.
Financial experts may analyze claims, deposits, contracts, ownership records, ledgers, taxes, refunds, denials, expenses, and transfers, while jurors decide whether payments reflect ordinary compensation, proceeds of knowing fraud, or mixtures requiring transaction-level separation.
Three Claims Provide a Narrow Transactional Test
The three substantive counts identify two abdominal aorta ultrasound claims and one broader cardiovascular panel, carrying approximate billed amounts of $150, $150, and $975 on dates falling between October 2023 and October 2024.
Their relatively modest amounts demonstrate that a substantive fraud count can focus upon a specific alleged execution even when prosecutors describe years of conduct and tens of millions of dollars to establish the surrounding scheme.
For each claim, jurors may need to determine who recruited the athlete, recorded medical information, selected diagnoses, performed testing, reviewed images, entered provider details, transmitted billing data, received payment, and understood any alleged falsity.
The defense can insist that the government prove every charged transaction beyond a reasonable doubt, whereas prosecutors may argue that recurring practices, common personnel, standardized paperwork, and coordinated financial arrangements reveal how each selected claim operated.
An August 2022 Exchange May Illuminate Knowledge
The indictment describes an August 2022 text exchange in which Finkelstein allegedly said he did not read abdominal aorta ultrasounds, although claims connected with those services purportedly continued through approximately January 2024 within the operation.
Prosecutors may characterize that communication as direct notice that billed interpretations did not match actual medical practice, especially when considered alongside later claims, approval records, payer appeals, recurring compensation, and Finkelstein’s corporate ownership and professional responsibilities.
Defense attorneys can request the complete conversation and surrounding workflow evidence, arguing that shorthand language may concern assignment, terminology, technical reading responsibilities, or another operational context materially different from the prosecution’s proposed interpretation at trial.
Jurors should evaluate the exchange with authenticated records and witness explanation rather than treating an isolated fragment as self-proving, because authorship, meaning, timing, surrounding events, and connection to charged claims remain factual questions.
The Government Will Present an Integrated Narrative
At trial, prosecutors are likely to connect marketing, campus access, referral payments, standardized testing, false diagnoses, disputed service locations, rapid approvals, insurer appeals, corporate structures, interstate transmissions, reimbursements, and personal payments into one alleged scheme.
That integrated presentation can make complicated evidence understandable, but the government must still establish the legal elements of each count without allowing a broad narrative, large totals, or disturbing medical allegations to substitute for offense-specific proof.
Witnesses may include school personnel, athletes, relatives, sonographers, billing employees, software custodians, insurer representatives, investigators, financial analysts, and medical experts, although publicly available materials do not yet provide a final trial witness list.
Documents may supply continuity across years, while testimony can explain why entries were created, who exercised authority, whether warnings were communicated, what payers understood, and how participants divided clinical, administrative, technical, and financial responsibilities.
The Defense Can Divide Roles and Challenge Attribution
Defense lawyers may separate Finkelstein’s medical work from campus marketing, scheduling, questionnaire processing, diagnosis coding, credential verification, claim submission, appeal preparation, corporate formation, payment routing, and other functions allegedly performed by employees or co-conspirators.
They may argue that services had preventive value, employees made unauthorized entries, payer requirements varied, platform logs were incomplete, compensation was lawful, and disputed clinical interpretations reveal professional disagreement rather than an intentional agreement to defraud.
The defense can challenge cooperating witnesses, incomplete message excerpts, statistical samples, database exports, expert assumptions, chain of custody, missing records, and financial tracing while demanding proof connecting Finkelstein personally with each material misrepresentation.
Prosecutors may answer with repetition, ownership authority, multistate licensing, recorded communications, implausibly brief approvals, continued billing after warnings, disputed appeals, and recurring payments, arguing that the combined evidence supports knowing participation rather than innocent distance.
Expert Testimony Will Translate Specialized Evidence
Cardiology experts may explain diagnostic necessity, image interpretation, preliminary findings, screening limitations, review times, and escalation duties, helping jurors assess whether the alleged clinical practices were reasonable, negligent, or evidence of deliberate billing deception.
Billing specialists can describe diagnosis codes, place-of-service entries, ordering-provider requirements, coverage criteria, denials, appeals, and materiality, while emphasizing that the rules governing commercial plans, Medicaid, federal employees, and veterans may not be identical.
Software experts may reconstruct audit logs, access histories, electronic signatures, report changes, and system limitations, whereas credentialing witnesses could address whether sonographers satisfied the professional or contractual qualifications applicable at particular campus events.
Competing experts can reach different conclusions in good faith, leaving jurors to compare methods, source data, assumptions, qualifications, internal consistency, and cross-examination before deciding which opinions clarify the evidence and which deserve limited weight.
Privacy Protections Will Matter Throughout Trial Preparation
Student medical questionnaires, cardiovascular images, insurance details, and family communications contain sensitive personal information, including records belonging to individuals who may never testify or appear within the three substantive claim counts selected by prosecutors.
Protective orders, redactions, sealed filings, restricted databases, controlled expert access, and courtroom procedures can preserve legitimate privacy interests without preventing either side from reviewing evidence necessary for prosecution, defense preparation, expert evaluation, or meaningful cross-examination.
Schools and healthcare organizations responding to subpoenas must preserve relevant materials while avoiding unnecessary public disclosure, unauthorized alteration, selective destruction, or informal communication that could compromise confidentiality and the integrity of the federal proceeding.
The court may need to balance public access with patient dignity whenever motions or exhibits discuss identifiable medical information, particularly because the allegation involving a deceased athlete carries intense public interest and exceptional emotional sensitivity.
The Jury Must Separate Misconduct from Criminal Fraud
An indictment records accusations approved for prosecution by a grand jury, but it is not trial evidence and cannot establish whether the records are authentic, the witnesses are reliable, the expert opinions are sound, or Finkelstein possessed the required intent.
Jurors may conclude that a business operation was careless, aggressive, poorly supervised, medically questionable, or administratively disorganized without necessarily finding every required element of healthcare fraud or conspiracy proved beyond a reasonable doubt at trial.
Conversely, prosecutors do not need to show that every service was worthless if they establish the charged scheme, material deception, required mental state, and specific executions through evidence satisfying Cannon’s final instructions on the governing law.
Finkelstein has no obligation to prove innocence, and any reasonable doubt concerning knowledge, agreement, attribution, materiality, claim content, or participation must be resolved through acquittal on the count affected by that unresolved doubt.
Schools and Insurers Can Act Before the Verdict
Colleges reviewing outside medical vendors should verify clinical purpose, professional credentials, referral compensation, student consent, insurance billing, data security, result interpretation, escalation of abnormal findings, and the institution’s responsibility to communicate follow-up recommendations clearly, accurately, and promptly.
Student athletes deserve understandable notice explaining whether testing is optional, which benefit program may receive claims, what diagnoses could enter permanent records, who reviews images, and where reliable clinical follow-up will be available.
Insurers can examine repeated testing bundles, identical diagnoses, improbable service locations, concentrated campus dates, exceptionally brief approval intervals, high-volume ordering providers, and unusual appeals without treating analytical anomalies as automatic proof of fraud.
The allegations also show why services marketed as free can carry significant financial consequences: an athlete may pay nothing at the event, while an insurer later receives claims whose accuracy depends on complex clinical and administrative representations.
Public Communication Should Track the Court Record
Healthcare companies, schools, and professionals facing comparable scrutiny need disciplined communication that informs affected communities without exposing protected records, influencing witnesses, contradicting counsel, minimizing safety concerns, or presenting untested accusations as established facts.
Amicus International Consulting’s crisis public relations guidance emphasizes assessment, planning, and consistent messaging, principles that can support responsible stakeholder communication while legal counsel manages evidence, disclosure obligations, confidentiality, and courtroom strategy during prolonged litigation.
Its approach to rebuilding a damaged public reputation similarly favors sustained, verifiable communication, although ethical reputation work cannot erase authentic court records, manufacture exoneration, suppress legitimate journalism, or replace accountability after proven wrongdoing.
Responsible reporting should distinguish accusations from findings, claims submitted from payments received, and scheduling updates from adjudication, while avoiding the inaccurate suggestion that this indictment describes a traditional Medicare scheme when its listed payers are different.
April 5 Will Test the Allegations Under Jury Rules
If trial begins on schedule, prosecutors will ask jurors to view years of medical, corporate, digital, and financial evidence as connected parts of knowing deception, while defense lawyers will challenge every asserted link and offer lawful alternative explanations.
The proceeding will place technical claim data beside human testimony, electronic timestamps beside medical judgment, and substantial financial totals beside three specific transactions, requiring jurors to move carefully between the case’s broad narrative and count-by-count proof.
For athletes and families, the prosecution carries significance beyond reimbursement because it asks whether services promoted in the language of safety were supported by professional attention, accurate records, qualified personnel, and honest communication with insurers.
For healthcare organizations, the trial may become a national compliance lesson about how preventive screening, remote review, multistate licensing, campus partnerships, automated billing, and referral relationships can create risk when responsibility becomes fragmented or opaque.
Jason Finkelstein remains presumed innocent as the September status conference, March calendar call, and April trial approach, and the Justice Department’s case update marks a scheduling milestone rather than a finding that any allegation has been proved.